TLSA NASDAQ
Tiziana Life Sciences Ltd
1W: +10.9%
1M: +20.2%
3M: -4.3%
YTD: -30.0%
1Y: -42.6%
3Y: +67.2%
5Y: -25.8%
$1.12
-0.02 (-1.75%)
Weekly Expected Move ±20.0%
$1
$1
$1
$1
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+90.2% ▲
Capital Expenditures
$15K
+0.0% ▲
5Y CAGR: +38.5%
Free Cash Flow
-$1M
+90.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+115.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$19M | -$17M | -$13M | -$14M | -$9M |
| Depreciation & Amort. | $66K | $105K | $42K | $76K | $99K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$216K | -$573K | -$949K | -$1M | -$441K |
| Other Non-Cash Items | $11M | $2M | -$3M | $3M | $9M |
| Operating Cash Flow | -$9M | -$16M | -$16M | -$12M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$93K | -$16K | $0 | $0 | -$15K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$2M | -$791K | -$52K |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $113K | -$1M | -$200K | $10K |
| Investing Cash Flow | -$93K | $96K | -$3M | -$992K | -$57K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | -$141K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$203K | -$113K | -$45K | -$94K | $28K |
| Financing Cash Flow | $54M | -$17K | -$45K | $32K | $4M |
| Net Change in Cash | $48M | -$18M | -$20M | -$13M | $2M |
| Cash End of Period | $48M | $31M | $15M | $936K | $3M |
| Free Cash Flow | -$9M | -$16M | -$16M | -$12M | -$1M |